DEDamla Ertürk

Damla Ertürk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Damla Ertürk has a total of 179 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Baseline Liver Metabolic Health in Newly Diagnosed People Living with HIV Compared with HIV-Negative Controls: Cross-Sectional Findings from the Prospective MASHIV-TR Cohort

    by Çiğdem Mermutluoğlu, Yeşim Taşova, Ayşe Özlem Mete, İlkay Karaoğlan, Hüsnü Pullukçu, Meliha Çağla Sönmezer, Dilara İnan, Funda Şimşek, Sıla Akhan, Tuba Damar Çakırca, et al.

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is an important comorbidity in people living with HIV (PLWH), yet most data derive from individuals receiving antiretroviral therapy (ART). In the baseline cross-sectional analysis of the prospective multicentre MASHIV-TR cohort (nine centres, Türkiye), we compared 250 newly diagnosed, ART-naïve PLWH and 161 HIV-negative controls. Hepatic steatosis and liver stiffness were assessed by vibration-controlled transient elastography; MASLD was defined as hepatic steatosis, indicated by CAP ≥ 248 dB/m together with at least one cardiometabolic risk factor. MASLD prevalence was similar in the two groups (25.2% vs. 30.4%; p = 0.245), and HIV status was not independently associated with MASLD. Triglyceride level was independently associated with CAP in PLWH (+10.69 dB/m per 50 mg/dL) and in controls (+9.26 dB/m), whereas CD4 and CD8 counts, the CD4/CD8 ratio and HIV-RNA were not associated with the liver outcomes. Before ART, hepatic steatosis tracked metabolic rather than HIV-specific markers.

  • AIDS-related and non-AIDS causes of in-hospital death among people living with HIV: a multicenter retrospective study

    by Tuğçe Şimşek Bozok, Gülden Ersöz, Damla Ertürk, Yeşim Taşova, Ilkay Karaoğlan, Irem Ece Darbaz, Dilara İnAn, Mustafa Kemal Çelen, Çiğdem Mermutluoğlu, Mehmet Çabalak, et al.

    Human immunodeficiency virus (HIV) infection remains a major global public health challenge despite substantial advances in antiretroviral therapy (ART). According to the Joint United Nations Progr...

  • Beyond viral suppression: determinants of health-related quality of life in a national HIV cohort in Turkiye

    by Zehra Karacaer, Merve Bozdag, Erdogan Asar, Aliye Bastug, Barcin Ozturk, Damla Erturk, Veysel Akca, Turhan Togan, Ilknur Esen Yildiz, Tuba Damar Cakirca, et al.

    This multicentre study evaluated Health-related Quality of Life (HRQoL) and identified sociodemographic and clinical determinants of physical and mental health outcomes in a large national HIV cohort in Turkiye. This cross-sectional study included 1303 adults across 23 centres. HRQoL was assessed using the Turkish MOS-HIV Health Survey, yielding Physical Health Summary (PHSS) and Mental Health Summary (MHSS) scores. HRQoL scores were dichotomised into "higher" (>50) and "lower" (≤50) groups. Data were analysed via univariate tests and multivariable logistic regression. Participants (88.6% male; median age: 38) were primarily single, employed, and university graduates. The median CD4+ T-cell count and HIV RNA level were 627 cells/mm3 and <50 copy/mL, respectively. Median PHSS and MHSS were 57.25 and 50.57, respectively. While social/role functioning scored highest, health transition scored lowest. Lower PHSS was identified in 22.7% of participants, whereas 47.9% reported lower MHSS. Low education and high daily pill burden significantly increased the risk of lower HRQoL. Interestingly, lower income was independently associated with better HRQoL, while older age and psychiatric treatment correlated with better MHSS. Despite robust physical HRQoL, mental health remains a significant challenge. To achieve "Fourth 90" targets, interventions should prioritise health literacy and integrated mental health services within HIV care.Abbreviations: ART: antiretroviral therapy; CF: cognitive functioning; CI: confidence interval; EF: energy/fatigue; GH: general health perception; HAART: highly active antiretroviral therapy; HD: health distress; HIV: human immunodeficiency virus; HL: Hosmer-Lemeshow; HRQoL: health-related quality of life; HT: health transition; MHS: mental health summary; MHSS: mental health summary score; MOS-HIV: medical outcomes study HIV health survey; OR: odds ratio; P: pain; PF: physical functioning; PHS: physical health summary; PHSS: physical health summary score; PLWH: people living with HIV; QL: quality of life; RF: role function; RNA: ribonucleic acid; SF: social function; UNAIDS: joint United Nations programme on HIV/AIDS.

  • Open Access

    Multicenter Point-Prevalence Study of Carbapenem-Resistant Klebsiella spp. in Türkiye: Epidemiology, Antimicrobial Resistance, and Infection Control Practices

    by Esra Erdem Kıvrak, Deniz Özer, Sinan Mermer, Ahmet Sertçelik, Hasip Kahraman, Müge Toygar Deniz, Damla Ertürk, Arzu Nazlı, Hüseyin Aytaç Erdem, Ongun Yeniçeri, et al.

    Background: Carbapenem-resistant Klebsiella spp. have emerged as major healthcare-associated pathogens worldwide, posing significant therapeutic and infection control challenges. Despite the growing burden of antimicrobial resistance, contemporary multicenter epidemiological data regarding carbapenem-resistant Klebsiella spp. in Türkiye remain limited. This study aimed to determine the culture-based prevalence of carbapenem-resistant Klebsiella spp. and to describe the clinical, microbiological, and institutional characteristics associated with these organisms. Materials and Methods: This multicenter cross-sectional point-prevalence study was conducted in seven tertiary-care hospitals located in different regions of Türkiye. On 19 February 2026, all hospitalized adult patients and microbiological cultures obtained on the study day were evaluated. Demographic, clinical, microbiological, antimicrobial treatment, infection control, and hospital-level data were collected using a standardized case report form. Culture-based prevalence estimates were calculated with 95% confidence intervals (CIs). Results: A total of 26 patients with carbapenem-resistant Klebsiella spp. colonization and/or infection were included. The mean age was 68.5 ± 14.1 years, and 61.5% were male. Most patients had at least one comorbidity (84.6%), and recent antibiotic exposure was common (88.5%). Urinary tract infection was the most frequently identified infection type (53.8%), followed by pneumonia (19.5%) and bloodstream infection (19.2%). Urinary catheterization was present in 73.1% of patients, while central venous catheters and mechanical ventilation were present in 46.2% and 34.6%, respectively. Ceftazidime–avibactam susceptibility results were available for 20 isolates, of which 12 (60.0%; 95% CI, 38.66–78.12) were resistant. Colistin susceptibility results were available for 17 isolates, of which four (23.5%; 95% CI, 9.56–47.26) were resistant. The culture-based prevalence of carbapenem-resistant Klebsiella spp. was 1.69% (95% CI, 1.16–2.46) among all cultures obtained on the study day and 8.94% (95% CI, 6.17–12.77) among culture-positive specimens. Conclusions: Carbapenem-resistant Klebsiella spp. remain important healthcare-associated pathogens in Türkiye, particularly among patients with substantial healthcare exposure, invasive device use, and recent antibiotic treatment. Continued surveillance, strengthened infection prevention measures, and expanded molecular characterization are essential for improving the understanding and control of antimicrobial resistance in the country.

  • Complications After Kidney Transplantation

    by Ayşegül Yetişir, Mehmet Taylan Peköz, Ahmet Yusuf Ertürk, Yasemin Aydınalp Camadan, Tolga Köşeci, Mete Sucu, M. Gürkan Arıkan, Muhammed Dağkıran, İlda Tanrısever Pehlivan, İsmail Can Karacaoğlu, et al.

  • Infections and Prophylaxis Following Kidney Transplantation

    by Damla Ertürk

    Although kidney transplantation is one of the most effective treatment options for end-stage renal disease, infections in the post transplant period are among the primary complications that determine patient and graft outcomes. The incidence and spectrum of these infections vary depending on surgical complications, allograft function, the intensity of the immunosuppressive regimen used, and prophylactic measures. In the early period, surgical site infections, catheter and catheter related infections, and hospital acquired bacterial infections are predominant, while opportunistic pathogens such as cytomegalovirus (CMV), BK polyomavirus, and Pneumocystis jirovecii become more prominent within the first 6 months. In the late phase, community-acquired infections predominate; however, the risk of opportunistic infections persists in patients receiving intensive or repeated immunosuppression. Urinary tract infections are the most common group of infections in kidney transplant recipients and are particularly associated with graft dysfunction, bacteremia, and hospitalization in the early phase. Although fungal infections are less common, they require early diagnosis and appropriate antifungal treatment due to their high mortality rate. Prophylactic and preemptive strategies play a critical role in the management of these infections, which directly impact both patient and graft survival. In this section, post-kidney transplant infections are addressed within a time-based framework; their clinical characteristics, diagnostic approach, treatment principles, and current prophylaxis strategies are summarized.

  • Open Access

    Missed opportunities for HIV testing in hospitalised adults in türkiye: ındicator conditions and testing coverage in a national multicentre point-prevalence survey (HIV-ICs-TR)

    by Yeliz Çiçek, Mustafa Kemal Çelen, Hüsnü Pullukçu, Seyit Ali Büyüktuna, Fatma Kesmez Can, Damla Ertürk, Buket Erturk Sengel, Hanife Nur Karakoc Parlayan, İlKnur Esen Yıldız, Kemalettin Özden, et al.

    To quantify the prevalence of HIV testing indications among hospitalised adults in Türkiye, assess HIV testing coverage when clinically indicated, and identify missed diagnostic opportunities in a national multicentre point-prevalence survey. We conducted a national multicentre cross-sectional point-prevalence survey across tertiary referral hospitals from all seven geographical regions of Türkiye. Adult inpatients present at 08:00 on a predefined index day were assessed for predefined HIV testing indications, including AIDS-defining conditions, indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and conditions in which unrecognised HIV could substantially affect clinical management. Among 3,425 hospitalised adults without known HIV infection, 699 (20.4%) had at least one documented HIV testing indication. HIV testing was requested by the primary clinical team in 424/699 patients (60.7%). Testing was lowest in patients with indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and these conditions were independently associated with higher odds of non-performance of HIV testing by the primary clinical team than AIDS-defining conditions (corresponding adjusted odds ratio [aOR] 3.05, 95% confidence interval [CI] 1.67–5.81). In centres with a specialised HIV outpatient clinic, the odds of non-performance of HIV testing by the primary clinical team were independently lower among patients with an appropriate testing indication (corresponding aOR 0.64, 95% CI 0.43–0.95). Following study-team facilitation, overall testing coverage increased to 677/699 (96.9%). Three reactive screening results were identified, including two confirmed new HIV diagnoses. HIV testing indications were common among hospitalised adults in Türkiye, but non-performance of HIV testing by the primary clinical team remained frequent, particularly for non-AIDS indicator conditions. Strengthening indicator-condition-guided testing through structured clinical pathways and institutional HIV expertise may reduce non-performance and support earlier HIV diagnosis.

  • Open Access

    Nontuberculosis Mycobacterial Infections: A Series of 14 Cases from a Tertiary Care Center in Türkiye

    by Damla Ertürk, Melek Tutku Kaçar-Şahin, Sümeyra Demir, Aslıhan Candevir, Süheyla Kömür, Ferit Kuşçu, Filiz Kibar, Ayşe Seza İnal, Behice Kurtaran, Yeşim Taşova

    Objectives: Nontuberculous mycobacteria (NTM) are emerging opportunistic pathogens with an increasing global incidence. However, epidemiological data and treatment outcomes remain limited in Türkiye. This study aimed to evaluate the clinical characteristics, species distribution, and treatment outcomes of NTM infections in a tertiary center in Türkiye. Materials and Methods: A retrospective analysis was conducted of patients diagnosed with NTM infection between 2021 and 2025 in the Department of Infectious Diseases and Clinical Microbiology. The diagnosis was established according to the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) criteria. Demographic characteristics, risk factors, radiological findings, microbiological profiles, antimicrobial susceptibility patterns, treatment regimens, and clinical outcomes were analyzed. Results: Fourteen patients were included in the study. The mean age was 50.1 ± 13.8 years, and nine patients were male. Underlying risk factors were present in eight patients, including human immunodeficiency virus (HIV) infection (n = 4), malignancy (n = 3), bronchiectasis (n = 1), and chronic obstructive pulmonary disease (COPD) (n = 1). The most frequently identified species were Mycobacterium kansasii (n = 5) and Mycobacterium abscessus (n = 5), followed by Mycobacterium avium, Mycobacterium simiae, Mycobacterium gordonae, and Mycobacterium lentiflavum (n = 1 each). Pulmonary involvement was observed in 10 patients, with nodular lesions in nine and bronchiectasis in five. Among isolates with available antimicrobial susceptibility results (n = 13), susceptibility to clarithromycin, moxifloxacin, linezolid, and amikacin was observed in 12 isolates, whereas resistance was most frequently detected to ciprofloxacin (n = 10) and trimethoprim-sulfamethoxazole (n = 9). Of the 12 patients who initiated treatment, complete clinical response was achieved in nine and partial response in one; two patients with malignancy died before treatment initiation. Conclusion: M. kansasii and M. abscessus were the most frequently identified NTM species in this cohort. Favorable treatment outcomes were observed when therapy was guided by antimicrobial susceptibility results. Species-level identification and susceptibility testing are essential for optimal disease management and strengthening diagnostic capacity. Keywords: Nontuberculous mycobacteria, Mycobacterium kansasii, Mycobacterium abscessus, antimicrobial susceptibility, pulmonary infection, HIV

  • Open Access

    Pulmonary complications in people living with HIV: a retrospective evaluation of the etiological spectrum and mortality-associated factors

    by Damla Ertürk, Aslıhan Candevir, Ayşe Akkaya, Süheyla Kömür, Onur Acar, Ferit Kuşçu, Ayşe Seza İnal, Behice Kurtaran, Yeşim Taşova

    Pulmonary complications are a major cause of poor outcomes in people living with HIV, yet data on the etiology and mortality predictors remain limited, par

  • Assessment of awareness and use of electronic cigarettes among people living with HIV

    by Damla Ertürk, Kübra Bavlı, Ferit Kuşçu, Pelin Duru Çetinkaya, Aslıhan Candevir, Süheyla Kömür, Onur Acar, Ayşe Seza Inal, Yeşim Taşova

    Tobacco use is disproportionately high among people living with HIV (PLWH), increasing tobacco-related morbidity and mortality and potentially undermining antiretroviral therapy adherence. We conducted a cross-sectional survey of 88 PLWH attending a university infectious diseases outpatient clinic (mean age 40.8 ± 10.9 years; 97.7% male). Sociodemographic characteristics, smoking history, quit attempts, and awareness of electronic cigarettes (e-cigarettes) were collected using a structured questionnaire, and nicotine dependence was measured with the Fagerström Nicotine Dependence Test. Mean dependence score was 3.94 ± 2.55 and was higher in participants with lower versus higher education (4.45 ± 2.62 vs 3.17 ± 2.26; mean difference 1.28, 95% CI 0.24 to 2.32; p = 0.020). Although 76.1% had attempted to quit, only 18.2% reported receiving professional support. Friends were the main source of e-cigarette information (60.2%). Only 21.6% considered e-cigarettes a tobacco product, while 44.3% did not. Most participants (76.1%) believed e-cigarettes are harmful. Smoking cessation services embedded in HIV care should address nicotine dependence and misinformation about e-cigarettes through targeted, multidisciplinary interventions.